Edwards Lifesciences (NYSE:EW) just reported results for the first quarter of 2024.
- Edwards Lifesciences reported earnings per share of 66 cents. This was above the analyst estimate for EPS of 64 cents.
- The company reported revenue of $1.60 billion.
- This was 1.78% better than the analyst estimate for revenue of $1.57 billion.